The "Viral Vector Vaccines - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Viral Vector Vaccines was estimated at US$773.4 Million in ...
In this article, ReiThera's scientific and operational leaders discuss ReiThera’s proprietary platforms, process development ...
Vaccine manufacturing is challenged by stringent global regulations, essential for ensuring safety and efficacy, with ...
Computational tool improves recombinant virus design efficiency and yield.This innovative in-house development is a key component of Transgene’s ...
We tend to just think of viruses in terms of their damaging impacts on human health and lives. But viruses can also be used to benefit human health, agriculture and the environment. Existing ...
A new study has shown promising results for a nasal COVID-19 vaccine, according to researchers at the Institute of Virology at Freie Universität Berlin in Germany. When two doses of the live nasal ...
Live attenuated vaccines mimic natural infections, providing strong immunity but require refrigeration and caution for immunocompromised individuals. Subunit vaccines offer targeted immunity without ...
AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side ...
The training brought together journalists, scientists, and health communicators to deepen their understanding of vaccines, ...
A new study has shown promising results for a nasal COVID-19 vaccine, according to researchers at the Institute of Virology at Freie Universität Berlin in Germany. When two doses of the live nasal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback